跳至主要内容
临床试验/NCT02004613
NCT02004613已完成4 期

Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery

The Cleveland Clinic1 个研究点 分布在 1 个国家目标入组 798 人开始时间: 2013年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
798
试验地点
1
主要终点
Number of Patients With Delirium

研究概览

简要总结

Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery

详细描述

The investigator goal is to evaluate the effects of intraoperative and postoperative dexmedetomidine sedation (versus placebo after cardiac surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-85 years old;
  • Scheduled for cardiac surgery with bypass (CABG, valve, or combined);
  • Able to provide a written informed consent;
  • Hemodynamically stable (heart rate>= 55).

排除标准

  • Sick sinus syndrome or Wolff-Parkinson-White syndrome
  • Atrio-ventricular block
  • Hypersensitivity or known allergy to dexmedetomidine
  • Hepatic disease, e.g. twice the normal level of liver enzymes
  • Atrial fibrillation within 1 preoperative month;
  • Permanent pacemaker;
  • Use of amiodarone or dexmedetomidine within the last 30 days;
  • Patients with an ejection fraction under 30% or who had severe heart failure
  • Myocardial infarction in the previ¬ous 7 days;
  • Body mass index =< 40 (BMI= mass (kg) / height (m)2);
  • Those taking clonidine within last 48 hours.

研究组 & 干预措施

Dexmedetomidine

Active Comparator

Dexmedetomidine infusion, without a bolus dose, (or a comparable volume of placebo) will be initiated before the surgical incision at a rate of 0.1 mcg/kg/hr at the end of bypass, the dose will be increased to 0.2 mcg/kg/hr. Postoperatively patients will continue to receive the study medication at a rate of 0.4mcg/kg/hr. The study medication infusion will be continued for a total of 24 hours from the initial administration time intra-operatively.

干预措施: Dexmedetomidine (Drug)

Placebo

Placebo Comparator

normal saline administration matching dexmedetomidine rate of infusion.

干预措施: Placebo (Drug)

结局指标

主要结局

Number of Patients With Delirium

时间窗: From the end of surgery to postoperative day 5

The occurrence of postoperative delirium

Number of Patients With Atrial Arrhythmia

时间窗: From the end of surgery to postoperative day 5

The occurrence of postoperative atrial arrhythmias

次要结局

  • Number of Patients With Acute Kidney Injury(From the end of surgery to postoperative day 5)
  • Number of Patients With Incisional Pain(90 days after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alparslan Turan

Staff

The Cleveland Clinic

研究点 (1)

Loading locations...

相似试验